HRAS Q61L Mutation as a Possible Target for Non-Small Cell Lung Cancer: Case Series and Review of Literature by Laurent Mathiot, Guillaume Herbreteau, Siméon Robin, Charlotte Fenat, Jaafar Bennouna, Christophe Blanquart, Marc Denis, Elvire Pons-Tostivint

Get full text

Monitoring concentration and lipid signature of plasma extracellular vesicles from HR+ metastatic breast cancer patients under CDK4/6 inhibitors treatment by Mathilde Richard, Rosalie Moreau, Mikaël Croyal, Laurent Mathiot, Jean‐Sébastien Frénel, Mario Campone, Aurélien Dupont, Julie Gavard, Gwennan André‐Grégoire, Laëtitia Guével

Get full text

Phase 1 first-in-human dose-escalation study of ANV419 in patients with relapsed/refractory advanced solid tumors by Stephane Champiat, Francois-Xavier Danlos, Aurélien Marabelle, Yohann Loriot, Julia Delahousse, Kaïssa Ouali, Santiago Ponce, Laurent Mathiot, David Combarel, Justin Cagnat, Sophie Broutin

Get full text

Durvalumab and tremelimumab in combination with metronomic oral vinorelbine for recurrent advanced cervical cancer: an open-label phase I/II study by Pernelle Lavaud, Esma Saada-Bouzid, Renaud Sabatier, Olivia Le Saux, Thibault de la Motte Rouge, Anthony Gonçalves, Elodie Coquan, Jean-Sébastien Frenel, Marta Jiménez, Alice Hervieu, Laurent Mathiot, François Legrand, Claire Cropet, Edith Borcoman, Emmanuelle Charafe

Get full text